Literature DB >> 26780457

Perforin Promotes Amyloid Beta Internalisation in Neurons.

Erica Lana1, Mahbod Khanbolouki2, Charline Degavre2, Eva-Britt Samuelsson3, Elisabet Åkesson3, Bengt Winblad2, Evren Alici4, Christina Unger Lithner1, Homira Behbahani5.   

Abstract

Studies on the mechanisms of neuronal amyloid-β (Aβ) internalisation are crucial for understanding the neuropathological progression of Alzheimer's disease (AD). We here investigated how extracellular Aβ peptides are internalised and focused on three different pathways: (i) via endocytic mechanisms, (ii) via the receptor for advanced glycation end products (RAGE) and (iii) via the pore-forming protein perforin. Both Aβ40 and Aβ42 were internalised in retinoic acid differentiated neuroblastoma (RA-SH-SY5Y) cells. A higher concentration was required for Aβ40 (250 nM) compared with Aβ42 (100 nM). The internalised Aβ40 showed a dot-like pattern of distribution whereas Aβ42 accumulated in larger and distinct formations. By confocal microscopy, we showed that Aβ40 and Aβ42 co-localised with mitochondria, endoplasmic reticulum (ER) and lysosomes. Aβ treatment of human primary cortical neurons (hPCN) confirmed our findings in RA-SH-SY5Y cells, but hPCN were less sensitive to Aβ; therefore, a 20 (Aβ40) and 50 (Aβ42) times higher concentration was needed for inducing uptake. The blocking of endocytosis completely inhibited the internalisation of Aβ peptides in RA-SH-SY5Y cells and hPCN, indicating that this is a major pathway by which Aβ enters the cells. In addition, the internalisation of Aβ42, but not Aβ40, was reduced by 55 % by blocking RAGE. Finally, for the first time we showed that pore formation in cell membranes by perforin led to Aβ internalisation in hPCN. Understanding how Aβ is internalised sheds light on the pathological role of Aβ and provides further ideas of inhibitory strategies for preventing Aβ internalisation and the spreading of neurodegeneration in AD.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid β peptides; Endocytosis; Human primary neurons; Perforin; RAGE; SH-SY5Y

Mesh:

Substances:

Year:  2016        PMID: 26780457     DOI: 10.1007/s12035-016-9685-9

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  52 in total

Review 1.  Amyloidogenic protein-membrane interactions: mechanistic insight from model systems.

Authors:  Sara M Butterfield; Hilal A Lashuel
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-02       Impact factor: 15.336

2.  Dynasore, a cell-permeable inhibitor of dynamin.

Authors:  Eric Macia; Marcelo Ehrlich; Ramiro Massol; Emmanuel Boucrot; Christian Brunner; Tomas Kirchhausen
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

Review 3.  LRP in amyloid-beta production and metabolism.

Authors:  Guojun Bu; Judy Cam; Celina Zerbinatti
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

4.  The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Authors:  Camilla A Hansson Petersen; Nyosha Alikhani; Homira Behbahani; Birgitta Wiehager; Pavel F Pavlov; Irina Alafuzoff; Ville Leinonen; Akira Ito; Bengt Winblad; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

5.  Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis.

Authors:  Tom Kirchhausen; Eric Macia; Henry E Pelish
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

6.  The perforin pore facilitates the delivery of cationic cargos.

Authors:  Sarah E Stewart; Stephanie C Kondos; Antony Y Matthews; Michael E D'Angelo; Michelle A Dunstone; James C Whisstock; Joseph A Trapani; Phillip I Bird
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

Review 7.  Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition.

Authors:  M E Harris-White; S A Frautschy
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-10

8.  Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists.

Authors:  X Bi; C M Gall; J Zhou; G Lynch
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 9.  Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

Authors:  Velandai Srikanth; Annette Maczurek; Thanh Phan; Megan Steele; Bernadette Westcott; Damian Juskiw; Gerald Münch
Journal:  Neurobiol Aging       Date:  2009-05-22       Impact factor: 4.673

10.  CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature.

Authors:  Sharon E Miller; Signe Mathiasen; Nicholas A Bright; Fabienne Pierre; Bernard T Kelly; Nikolay Kladt; Astrid Schauss; Christien J Merrifield; Dimitrios Stamou; Stefan Höning; David J Owen
Journal:  Dev Cell       Date:  2015-04-20       Impact factor: 12.270

View more
  4 in total

1.  Glycosyl chains and 25-hydroxycholesterol contribute to the intracellular transport of amyloid beta (Aβ-42) in Jurkat T cells.

Authors:  Neha Sharma; KeangOK Baek; Huong T T Phan; Naofumi Shimokawa; Masahiro Takagi
Journal:  FEBS Open Bio       Date:  2017-05-18       Impact factor: 2.693

2.  Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis.

Authors:  Eric L Goldwaser; Nimish K Acharya; Hao Wu; George A Godsey; Abhirup Sarkar; Cassandra A DeMarshall; Mary C Kosciuk; Robert G Nagele
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 3.  Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.

Authors:  Jelena Osmanovic Barilar; Ana Knezovic; Ana Babic Perhoc; Jan Homolak; Peter Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2020-02-06       Impact factor: 3.575

4.  Targeting of Perforin Inhibitor into the Brain Parenchyma Via a Prodrug Approach Can Decrease Oxidative Stress and Neuroinflammation and Improve Cell Survival.

Authors:  Janne Tampio; Johanna Huttunen; Ahmed Montaser; Kristiina M Huttunen
Journal:  Mol Neurobiol       Date:  2020-08-05       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.